StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$97.50+1.19 (+1.24%)

Close on Nov 17, 2026Market cap $4.60BP/E –Yield –

BillionToOne cash

Cash and short-term investments held at the end of each period.

BillionToOne's cash was $561.51M at Sep 30, 2026. For fiscal 2025 it was $495.98M, up 159.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$495.98M+159.0%
FY2024Dec 31, 2024$191.48M+96.9%
FY2023Dec 31, 2023$97.27M+77.8%
FY2022Dec 31, 2022$54.70M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$561.51M+187.7%
Q2 FY2026Jun 30, 2026$548.63M+190.3%
Q1 FY2026Mar 31, 2026$537.45M+180.5%
Q4 FY2025Dec 31, 2025$495.98M+159.0%
Q3 FY2025Sep 30, 2025$195.15M-3.5%
Q2 FY2025Jun 30, 2025$188.96M+94.3%
Q1 FY2025Mar 31, 2025$191.60M+250.3%
Q4 FY2024Dec 31, 2024$191.48M–
Q3 FY2024Sep 30, 2024$202.29M–
Q4 FY2023Dec 31, 2023$97.27M–
Q4 FY2022Dec 31, 2022$54.70M–

More BillionToOne figures

See a number that looks wrong?